ArticleLung Cancer (Auckland, N.Z.)2022

Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation.

Danielle Brazel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.